ECRI Institute to Pick Up Where NGC Left Off
ECRI Institute announced plans this week to continue providing the centralized source of medical guidelines originally… Read more
HEOR Feature
Featured
PhRMA Proposes Drug Pricing Plan in Response to Trump’s Blueprint
The Pharmaceutical Research and Manufacturers of America has proposed its own plan to significantly alter how prescription drugs are priced, according… Read more
Blog Post Spotlights Two-Sided Risk for ACOs in MSSP
A recent blog post published on Health Affairs takes a look at the arguments for making health care providers move to two-sided risk in the Medicare… Read more
Are Biosimilars the Key to Boosting Access, Controlling Prices in Oncology?
Cost-saving agents like biosimilars, compounded with more cost-efficient drug development strategies, could be the key to developing a more… Read more
